Related Experiment Video
Updated: Aug 9, 2026

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)
Published on: September 14, 2010
Clinical aspects of 100 patients with Kawasaki disease
E J Tizard1, A Suzuki, M Levin
1Department of General Paediatrics and Nephrology, Hospital for Sick Children, London.
Insights
Kawasaki disease can lead to serious cardiac issues, including coronary artery aneurysms. Early treatment with intravenous immunoglobulin is recommended to mitigate cardiac involvement in pediatric patients.
Area of Science:
- Pediatrics
- Cardiology
- Rheumatology
Background:
- Kawasaki disease is a significant cause of acquired heart disease in children.
- Cardiac involvement is a major concern, potentially leading to long-term cardiovascular complications.
Purpose of the Study:
- To analyze the clinical features, cardiac involvement, and treatment outcomes of Kawasaki disease over a 12-year period.
- To identify factors associated with cardiac complications and discuss long-term cardiovascular sequelae.
Main Methods:
- Retrospective review of 101 Kawasaki disease episodes in 100 patients.
- Analysis of laboratory findings, cardiac involvement (pericardial effusion, coronary artery aneurysms), and treatment regimens.
- Correlation of laboratory variables with cardiac involvement.
Main Results:
- 35% of patients experienced cardiac involvement, with one fatality due to ischemic complications.
- Leukocytosis and thrombocytosis were common laboratory findings and significantly associated with cardiac involvement.
- Treatment evolved to include routine intravenous immunoglobulin for early-diagnosed cases.
Conclusions:
- Kawasaki disease poses a substantial risk of cardiac complications in children.
- Leukocytosis and thrombocytosis are predictive markers for cardiac involvement.
- Long-term cardiovascular consequences require further investigation, especially in light of adult atherosclerotic lesions resembling those in Kawasaki disease.
Abstract:
We report 101 episodes of Kawasaki disease in 100 patients seen over a 12 year period. A total of 35 patients had cardiac involvement ranging from pericardial effusion to coronary artery aneurysms with ischaemic complications, which resulted in death in one patient. Laboratory investigations showed leucocytosis, thrombocytosis, and a raised erythrocyte sedimentation rate to be common features and the first two variables were significantly associated with cardiac involvement. Treatment regimens changed over the study period. Aspirin was used in most patients often in conjunction with dipyridamole and from 1986 intravenous immunoglobulin was given routinely to those patients seen early in the illness. Additional therapeutic measures in individual patients included prostacyclin, heparin, streptokinase, and plasma exchange/exchange transfusion. Attention is drawn to the uncertainity of the long term cardiovascular consequences in the light of adults reported with premature atherosclerotic lesions of similar appearance to those seen in Kawasaki disease.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease III: Clinical Manifestations
Chronic Kidney Disease II: Clinical Manifestations
